Beth N. Peshkin

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

BRCAPRO Validation, Sensitivity of Genetic Testing of <i>BRCA1/BRCA2</i>, and Prevalence of Other Breast Cancer Susceptibility Genes

Donald A. Berry, Edwin S. Iversen, Daníel F. Guðbjartsson et al. · Journal of Clinical Oncology · 2002 · 506 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

T. Frank, Susan Manley, O. I. Olopade et al. · Journal of Clinical Oncology · 1998 · 462 citations

Medicine, Genetics, Oncology +17

Characterization of<i>BRCA1</i>and<i>BRCA2</i>Mutations in a Large United States Sample

Sining Chen, Edwin S. Iversen, Tara M. Friebel et al. · Journal of Clinical Oncology · 2006 · 325 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

A brief assessment of concerns associated with genetic testing for cancer: The multidimensional impact of cancer risk assessment (MICRA) questionnaire.

David Cella, Chanita Hughes, Amy H. Peterman et al. · Health Psychology · 2002 · 289 citations

Medicine, Genetics, Oncology +16